Literature DB >> 6089699

Hepatic resection in 125 patients.

T Tsuzuki, Y Ogata, S Iida, M Shimazu.   

Abstract

Hepatic resection was performed in 125 patients. Ninety-three of the 125 patients had malignant neoplasms; primary liver carcinoma in 61, metastatic liver carcinoma in 15, carcinoma of the bifurcation of the hepatic ducts in 16, and carcinoma of the gallbladder in one. Performance of hepatic resection was complicated by the presence of liver cirrhosis and jaundice in 42 and 19 patients, respectively. Nine of the 125 patients died within 30 days of the operations, with an operative mortality of 7.2%. Eight of the nine deaths were due to liver failure in the cirrhotic patients who underwent resection of more than two segments of the liver. None of the jaundiced patients died postoperatively. The three-year actuarial survival rates of the patients with hepatocellular carcinoma, metastatic liver carcinoma, and carcinoma of the bifurcation of the hepatic ducts were 31%, 56%, and 21% respectively.

Entities:  

Mesh:

Year:  1984        PMID: 6089699     DOI: 10.1001/archsurg.1984.01390210029008

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  15 in total

1.  A pre-operative chemoembolization therapy using lipiodol, cisplatin and gelatin sponge for hepatocellular carcinoma.

Authors:  S Imaoka; Y Sasaki; T Shibata; M Fujita; H Kasugai; J Kojima; S Ishiguro; H Ohigashi; O Ishikawa; I Fukuda
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Clinical decision analysis using microcomputers. A case of coexistent hepatocellular carcinoma and abdominal aortic aneurysm.

Authors:  J B Wong; A J Moskowitz; S G Pauker
Journal:  West J Med       Date:  1986-12

3.  Vascular occlusions for liver resections. Operative management and tolerance to hepatic ischemia: 142 cases.

Authors:  E Delva; Y Camus; B Nordlinger; L Hannoun; R Parc; H Deriaz; A Lienhart; C Huguet
Journal:  Ann Surg       Date:  1989-02       Impact factor: 12.969

4.  Regional therapy in the management of intrahepatic recurrence after surgery for hepatoma.

Authors:  Y Sasaki; S Imaoka; M Fujita; Y Miyoshi; H Ohigashi; O Ishikawa; H Furukawa; H Koyama; T Iwanaga; H Kasugai
Journal:  Ann Surg       Date:  1987-07       Impact factor: 12.969

5.  Can hepatic failure after surgery for hepatocellular carcinoma in cirrhotic patients be prevented?

Authors:  K Takenaka; T Kanematsu; K Fukuzawa; K Sugimachi
Journal:  World J Surg       Date:  1990 Jan-Feb       Impact factor: 3.352

6.  Selection of therapeutic modalities for hepatocellular carcinoma in patients with multiple hepatic lesions.

Authors:  M Monden; M Sakon; M Gotoh; T Kanai; K Umeshita; K S Wang; M Sakurai; C Kuroda; J Okamura; T Mori
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

7.  Micrometastatic colorectal cancer lesions in the liver.

Authors:  M Nanko; H Shimada; H Yamaoka; K Tanaka; H Masui; K Matsuo; H Ike; S Oki; M Hara
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

8.  Primary liver cancer in Hong Kong.

Authors:  W C Shiu
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

9.  Pathological study of small hepatocellular carcinoma: frequency of their invasion.

Authors:  K Wakasa; M Sakurai; J Okamura; C Kuroda
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

10.  Large hepatocellular cancers: hepatic resection or liver transplantation?

Authors:  O Søreide; A Czerniak; L H Blumgart
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.